JEROMY WILSON: Open Payments
NPI 1033394150 · WESTMINSTER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,394 in 70 payments from 22 companies in 2025. Trend: 2023 $1,080 · 2024 $1,192 · 2025 $1,394
Food & beverage: $1,394
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $272 |
| AstraZeneca Pharmaceuticals LP | 5 | $147 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $105 |
| Amgen Inc. | 5 | $90 |
| Lilly USA, LLC | 5 | $89 |
| PFIZER INC. | 4 | $81 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| Eisai Inc. | 4 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $59 |
Products named: VRAYLAR, JARDIANCE, BREZTRI, TRELEGY ELLIPTA, Leqembi, MOUNJARO, Kerendia, XIFAXAN.
Industry payments across CO — which companies pay providers there.
